Answers are grounded in this paper and cite their sources.
Non-inferiority trials are often done to ensure that a new therapy does not carry an unacceptably high risk of harm compared to existing therapies, with the maximally accepted excess risk defined b...
No takes yet. Share an insight, caveat, or question.
Björn Redfors (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: